Literature DB >> 4768552

Inheritance of two types of deficiency of human serum cholinesterase.

E M Scott.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4768552     DOI: 10.1111/j.1469-1809.1973.tb01821.x

Source DB:  PubMed          Journal:  Ann Hum Genet        ISSN: 0003-4800            Impact factor:   1.670


× No keyword cloud information.
  8 in total

Review 1.  Cocaine hydrolase gene therapy for cocaine abuse.

Authors:  Stephen Brimijoin; Yang Gao
Journal:  Future Med Chem       Date:  2012-02       Impact factor: 3.808

2.  A third type of serum cholinesterase deficiency in Eskimos.

Authors:  E M Scott; R C Wright
Journal:  Am J Hum Genet       Date:  1976-05       Impact factor: 11.025

3.  A family segregating for E1j and E1k at cholinesterase locus 1.

Authors:  R T Evans; J Iqbal; A A Dietz; T Lubrano; H M Rubinstein
Journal:  J Med Genet       Date:  1980-12       Impact factor: 6.318

Review 4.  Interception of cocaine by enzyme or antibody delivered with viral gene transfer: a novel strategy for preventing relapse in recovering drug users.

Authors:  Stephen Brimijoin
Journal:  CNS Neurol Disord Drug Targets       Date:  2011-12       Impact factor: 4.388

Review 5.  Prospects, promise and problems on the road to effective vaccines and related therapies for substance abuse.

Authors:  Stephen Brimijoin; Xiaoyun Shen; Frank Orson; Thomas Kosten
Journal:  Expert Rev Vaccines       Date:  2013-03       Impact factor: 5.217

6.  High incidence of the silent allele at cholinesterase locus I in Vysyas of Andhra Pradesh (S. India).

Authors:  P R Rao; K B Gopalam
Journal:  Hum Genet       Date:  1979-11-01       Impact factor: 4.132

7.  Human neutral alpha-glucosidase C: genetic polymorphism including a "null" allele.

Authors:  F Martiniuk; R Hirschhorn
Journal:  Am J Hum Genet       Date:  1980-07       Impact factor: 11.025

8.  Suxamethonium-the development of a modern drug from 1906 to the present day.

Authors:  H R Dorkins
Journal:  Med Hist       Date:  1982-04       Impact factor: 1.419

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.